When Health Minister Mark Butler rose in Question Time yesterday to highlight progress on access to blood cancer therapies, his intent was to demonstrate that the system is working, delivering access to cutting-edge treatments through the Pharmaceutical Benefits Scheme. Analyse the timelines.
If these can be presented as positives, then we really have become accustomed to terrible
March 26, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Territory partnership backs digital health push for diabetes, kidney and heart care
July 9, 2026 - - Latest News -
It might make sense to follow the process, mostly, but no need to keep patients waiting
July 9, 2026 - - Latest News -
Illumina taps medtech leader to head Australia and New Zealand operations
July 8, 2026 - - Latest News -
PYC Therapeutics names Thomas Ulmer as new chief financial officer
July 8, 2026 - - Australian Biotech -
In a perfect world, the minister would not be in this position, and he might question the timeline
July 8, 2026 - - Latest News -
Aegros completes Australia’s second large scale plasma fractionation plant
July 8, 2026 - - Latest News -
'But I've said it's really important that these two drugs stay on the PBS'
July 7, 2026 - - Latest News

